National Network Genomic Medicine Lung Cancer, Germany - Trial NCT05934032
Access comprehensive clinical trial information for NCT05934032 through Pure Global AI's free database. This phase not specified trial is sponsored by Prof. Dr. Juergen Wolf and is currently Recruiting. The study focuses on Carcinoma, Non-Small-Cell Lung. Target enrollment is 30000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Prof. Dr. Juergen Wolf
University of Cologne
Timeline & Enrollment
N/A
Apr 01, 2018
Dec 31, 2030
Primary Outcome
molecular testing,treatment patterns,overall survival,time to next treatment,progression free survival
Summary
Registry of the national Network Genomic Medicine Lung Cancer (nNGM), linking data on
 molecular diagnostics, clinical characteristics, treatment patterns and outcomes of subjects
 with non-small cell lung cancer (NSCLC) from 23 specialized cancer centres and more than 400
 general hospitals and oncological practices in Germany
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05934032
Non-Device Trial